Literature DB >> 6425217

Production and characterization of monoclonal antibodies to exotoxin A from Pseudomonas aeruginosa.

D R Galloway, R C Hedstrom, O R Pavlovskis.   

Abstract

Hybridomas secreting monoclonal antibodies specific for exotoxin A from Pseudomonas aeruginosa strain PA103 were derived from the fusion of spleen cells from mice immunized with: (i) purified exotoxin A, (ii) Formalin-treated exotoxin A, (iii) exotoxin A covalently coupled to Sepharose 4B, or (iv) P. aeruginosa-infected mice. All hybridomas were screened and selected by using an enzyme-linked immuno-adsorbent assay. All antibody isotypes were represented (immunoglobulins G, A, and M) as determined by enzyme-linked immunoadsorbent assay. The most productive fusions resulted from immunization with antigens coupled to an insoluble matrix, such as Sepharose 4B, or by infection of mice. Several hybridomas were selected and cloned by limiting dilution. The specificity of the monoclonal antibodies for exotoxin A was demonstrated by indirect immunoprecipitation of 125I-labeled exotoxin A followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis and by the immunoblotting technique. The protective ability of certain monoclonal antibodies was demonstrated in vitro by toxin neutralization in tissue culture and in vivo by prolonged survival time in the burned mouse infection model, after passive immunization. One monoclonal antitoxin displayed specificity for PA103-derived exotoxin yet failed to react with exotoxin purified from PAO-PR1 or PAO1, suggesting that structural differences exist between these exotoxins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6425217      PMCID: PMC263511          DOI: 10.1128/iai.44.2.262-267.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  25 in total

1.  NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin,.

Authors:  B H Iglewski; D Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

2.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

3.  Characteristics of nonbacteremic Pseudomonas pneumonia.

Authors:  J R Tillotson; A M Lerner
Journal:  Ann Intern Med       Date:  1968-02       Impact factor: 25.391

4.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

5.  The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. II. Effects of lecithinase and protease.

Authors:  P V Liu
Journal:  J Infect Dis       Date:  1966-02       Impact factor: 5.226

6.  Enhanced survival in burned mice treated with antiserum prepared against normal and burned skin.

Authors:  I A Holder; M Jogan
Journal:  J Trauma       Date:  1971-12

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Large-scale purification and characterization of the exotoxin of Pseudomonas aeruginosa.

Authors:  S H Leppla
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

9.  Pseudomonas bacteremia. Review of 108 cases.

Authors:  M R Flick; L E Cluff
Journal:  Am J Med       Date:  1976-04       Impact factor: 4.965

10.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model.

Authors:  D D Stieritz; I A Holder
Journal:  J Infect Dis       Date:  1975-06       Impact factor: 5.226

View more
  9 in total

1.  A human recombinant autoantibody-based immunotoxin specific for the fetal acetylcholine receptor inhibits rhabdomyosarcoma growth in vitro and in a murine transplantation model.

Authors:  S Gattenlöhner; H Jörissen; M Huhn; A Vincent; D Beeson; S Tzartos; A Mamalaki; B Etschmann; H K Muller-Hermelink; E Koscielniak; S Barth; A Marx
Journal:  J Biomed Biotechnol       Date:  2010-02-24

2.  Compatible-solute-supported periplasmic expression of functional recombinant proteins under stress conditions.

Authors:  S Barth; M Huhn; B Matthey; A Klimka; E A Galinski; A Engert
Journal:  Appl Environ Microbiol       Date:  2000-04       Impact factor: 4.792

3.  A human-human hybridoma secreting anti-Pseudomonas aeruginosa exotoxin-A monoclonal antibody with highly potent neutralizing activity.

Authors:  M Kuriyama; Y Ichimori; S Iwasa; K Tsukamoto
Journal:  Cytotechnology       Date:  1990-01       Impact factor: 2.040

4.  Cloning of a gene involved in regulation of exotoxin A expression in Pseudomonas aeruginosa.

Authors:  R C Hedstrom; C R Funk; J B Kaper; O R Pavlovskis; D R Galloway
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.609

5.  Functionally distinct monoclonal antibodies reactive with enzymatically active and binding domains of Pseudomonas aeruginosa toxin A.

Authors:  J K Chia; M Pollack; D Avigan; S Steinbach
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.609

6.  Nucleotide sequence and characterization of toxR: a gene involved in exotoxin A regulation in Pseudomonas aeruginosa.

Authors:  D J Wozniak; D C Cram; C J Daniels; D R Galloway
Journal:  Nucleic Acids Res       Date:  1987-03-11       Impact factor: 19.160

7.  Characterization of monoclonal antibody B7, which neutralizes the cytotoxicity of Pseudomonas aeruginosa exotoxin A.

Authors:  H F Shang; M L Yeh; C P Lin; J Hwang
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

8.  Binding of monoclonal antibody specific for domain Ia/II of Pseudomonas aeruginosa exotoxin A at pH 4 strongly neutralizes exotoxin A-induced cytotoxicity in cell culture and in vivo.

Authors:  H Ohtsuka; K Horigome; A Higuchi; N Nomura; H Ochi; S Yokota; T Kohzuki; H Noguchi
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.609

9.  His-426 of the Pseudomonas aeruginosa exotoxin A is required for ADP-ribosylation of elongation factor II.

Authors:  D J Wozniak; L Y Hsu; D R Galloway
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 12.779

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.